Selected publications
-
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.
Journal of Clinical Oncology.
2019
Academic Article
GET IT
Times cited: 10 -
Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma.
Leukemia and Lymphoma.
2018
Academic Article
GET IT
Times cited: 8 -
Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population.
Leukemia and Lymphoma.
2016
Academic Article
GET IT
Times cited: 13 -
NCCN Guidelines® insights: Non-Hodgkin's lymphomas, version 3.2016 featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2016
Article
GET IT
Times cited: 41 -
NCCN guidelines® insights multiple myeloma, version 3.2016 featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2016
Academic Article
GET IT
Times cited: 34 -
Diffuse large b-cell lymphoma version 1.2016: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2016
Article
GET IT
Times cited: 41 -
Central nervous system involvement in T-cell lymphoma: A single center experience.
Acta Oncologica.
2016
Academic Article
GET IT
Times cited: 16 -
Multiple myeloma, version 2.2016: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2015
Article
GET IT
Times cited: 36